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Despite of great advances in knowledge of heart failure (HF)
pathophysiology in recent years, few studies have been conducted in
populations with signiﬁcant prevalence of Chagas disease. With the
aim of evaluating the prevalence of anemia, renal dysfunction (RD)
andmalnutrition in patients with Chagasic cardiomyopathy (CCM)we
performed a cross-sectional study in a referral center for HF. Over a
four month time period, 121 HF patients underwent clinical,
nutritional and laboratory assessment, with subsequent blood sample
collection to perform laboratory assays such as complete blood count,
urea, creatinine, electrolytes, iron, ferritin and total capacity of iron
binding serum analyses. Presence of renal disease was assessed by
glomerular ﬁltration rate calculated using the Cockcroft and Gault
formula. Nutritional status was performed using body mass index,
using the World Health Organization criteria for adults and Lipschitz
for elderly patients. Triceps skinfold and subscapular skinfold
thickness were used to evaluate the adipose tissue reserve. To
evaluate the muscle mass reserve were used the corrected arm
muscle area andmid-armmuscle circumference for adults and elderly
patients, respectively.
The mean age was 53.4±14.9 years and 52.1% were male. The
presence of malnutrition, anemia and RD were diagnosed in 14.1%,
9.9% and 57.9% of patients, respectively.
CCM was the most frequent cause of HF corresponding to 33.1% of
cases. Anemia (p=0.033) and RD (p=0.02) were more frequent in
patients with low weight. We also observed a correlation between RD
degree and presence of anemia (pb0.001). There was no statistically
signiﬁcant difference betweenpatientswith andwithout CCM. Presence
of CCM was not associated with anemia (7.5 vs. 11.1, p=0.748) and
malnutrition (7.5 vs. 17.3, p=0.338). The RD frequency was 70% and
51.9% in patients with and without CCM, respectively (p=0.057).
Anemia is a common comorbidity in HF patients and is associated
with worse prognosis [1–3]. In this study, 9.9% of patients had anemia.
On date, this prevalence varies from 4% to 69.7%. This variation depends
on the diagnostic criteria and the analyzed population, increasing in
accordance to age and severity of the disease [1,2]. RD is also a common
complication in patients with HFand is associatedwith disease severity,
worse prognosis and higher anemia prevalence [4,5]. We found that
27.3% of patients had mild RD and 30.5% moderate to severe RD. Data
from previous studies reports RD prevalence near of 40% in HF patients
[6,7]. In this study, presence of anemia and RD was related to patient's
nutritional status. Anemia and RD was more frequently found in low
weight patients, while patients with normal weight, overweight or
obese had lower anemia and RD prevalence.
Regarding the nutritional status, the HF creates a complex catabolic
state, which occurs because of activation of several mechanisms such
as renin–angiotensin–aldosterone system and pro-inﬂammatory
cytokines [8,9], creating an inﬂammatory status that might be the
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reason for the three factor relationship (malnutrition, anemia, RD),
one being the cause for the other.
This study was performed in a town near to an endemic Chagas
disease area and found a high prevalence HF due to CCM. There are few
published studies relating anemia and RDwith HF inpatientswith CCM.
Chagas disease has a closely relation to the social and economic
development. Therefore, it is expected that this population has an
inadequate intake of nutrients, and bemore affected byanemia. However,
this study found no signiﬁcant difference in the prevalence of anemia
among patients with and without CCM. This ﬁnding can be explained by
the low socioeconomic development of whole population studied.
Usually studies on HF are made up primarily of patients with
systemic hypertension and coronary artery disease, which are RD
predisposing conditions. The population analyzed in this study differs
from these previous studies by the high prevalence of CCM. Even
though, we found high prevalence of RD in patients with Chagas
disease, comparing to those patients without CCM (70.0 vs. 51.9%,
p=0.057), showing a possible trend. This might be explained by
poorer access to health care encountered by this population, mainly
due to living on countryside. Another hypothesis is that CCM patients
have a greater predisposition to suffer thromboembolic events, which
often affect the kidneys [10], that can be related to decreased renal
function in these patients.
This is a retrospective study, with some pitfalls. It has a small
number of patients, and a convenience sample. Moreover, at the time
of data collection it was not surveyed other associated conditions that
could possibly inﬂuence hemoglobin and creatinine levels, such as
sickle cell anemia and parasitic infections.
However, this study conﬁrms data found in literature, inwhich there
is a strong association between anemia and RD in HF patients.
Furthermore, we found that malnutrition was closely associated to
anemia and RD. Therefore, it is important to consider a special attention
to prevention, early diagnosis and treatment of these comorbidities in
order to improve prognosis and patients' quality of life.
The authors of this manuscript have certiﬁed that they comply
with the Principles of Ethical Publishing in the International Journal of
Cardiology (Shewan and Coats 2010;144:1–2).
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Ultra small super-paramagnetic iron oxide
particles
It is well known that inﬂammation plays an important role in the
progression of vessel injury, restenosis and atherosclerosis after
percutaneous coronary intervention (PCI) [1–3]. Nowadays measure-
ments of inﬂammation effects by PCI involve angiography, clinic follow-
up, histopathology and various inﬂammation markers, but not direct
demonstrations in vivo non-invasively [1,4–6]. New introduction of high
resolution MRI with administration of ultra-small super-paramagnetic
iron oxide (USPIO) particles can depict and assess inﬂammation and
macrophage burden in atherosclerosis non-invasively [7,8]. Our aimwas
to establish USPIO enhanced MRI assessing vascular inﬂammation non-
invasively in vivo.
14 male New-Zealand rabbits (2.0–2.5 kg) received 2w of hyper-
lipidemic diet. Rabbits were generally anesthetized with an intra-
muscular injection of ketamine (75 mg/kg) and midazolam (3.75 mg/
kg). Balloon injuries underwent to right iliac arteries in GroupA (n=8),
and ligation of right femoral arteries in Group B (n=6). USPIO particles
(2 mg Fe/kg) [9] were infused intravenously. This study was approved
by the ethical committee for animal research of the Zhejiang University.
MR Imagingwasperformedona3.0 Tcommercial clinicalMR system
(Archieva, Philips Medical Systems, Netherlands) at baseline and 72 h
after operation. Animal was generally anesthetized. MR scans of right
iliac arteries were performed before surgery and at 72 h after contrast.
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